REGN Competitors & Alternatives

Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

REGN

Main Stock
$923.34
-2.35%
Tradestie Score
42
Market Cap
$63.59B
P/E Ratio
20.9
Revenue Growth
36.3%
Analyst Upside
+7.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 5/10 Drug Discovery Biotech Drug Design
Competitive Moat: Switching Cost
Core Technology Stack: VelocImmune, VelociGene, monoclonal antibody platforms, AI-driven target discovery
Major Customers 5
McKesson Cardinal Health AmerisourceBergen Specialty pharmacies Government payers
Critical Suppliers 4
Samsung Biologics Fujifilm Diosynth Raw material chemical suppliers Packaging contractors
Direct Ecosystem Rivals 4

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
AMGN Amgen Inc
$438.82
-1.14%
$160.70B 25.7 43 Compare
GILD Gilead Sciences Inc
$166.53
-1.45%
$137.92B - 47 Compare
VRTX Vertex Pharmaceuticals Inc
$520.66
-2.94%
$103.64B 34.5 47 Compare
ALNY Alnylam Pharmaceuticals, Inc.
$147.82
-1.06%
$60.38B 7.5 46 Compare
ARGX argenx SE American Depositary Shares
$942.04
+0.08%
$46.96B 32.8 43 Compare
ONC BeOne Medicines Ltd. American Depositary Shares
$399.70
-0.97%
$36.81B 51.7 43 Compare
INSM Insmed, Inc.
$144.46
+20.58%
$31.13B - 34 Compare
BNTX BioNTech SE American Depositary Share
$81.38
-2.26%
$24.57B - 49 Compare
BIIB Biogen Inc. Common Stock
$247.13
-1.70%
$22.61B 108.8 50 Compare
GMAB Genmab A/S ADS
$51.35
+0.75%
$19.56B 43.6 43 Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry